口服泛影葡胺治疗粘连性小肠不完全性梗阻

Treatment of the adhensive partial small-bowel obstruction by oral Meglumine Diatrizoate

目的探讨口服泛影葡胺治疗粘连性小肠不完全梗阻的方法及疗效。方法前瞻性分析我院1998～2002年口服泛影葡胺(A组)治疗粘连性小肠不完全性梗阻与传统保守治疗(B组)疗效比较。结果口服泛影葡胺组患者无死亡;平均排便时间、平均住院时间和平均保守治疗时间均显著短于传统保守治疗组(P<0.01),没有与泛影葡胺相关的低容量循环、吸入性肺炎、水电解质紊乱、肠梗阻加重及肠穿孔等并发症发生。结论口服泛影葡胺治疗粘连性小肠不完全性梗阻操作简单、完全、有效且并发症少,可有效缓解肠梗阻,缩短住院时间,值得在临床中推广使用。

Objective To study the method and effect in the treatment of adhensive partial small-bowel obstruction(APSO) by oral Meglumine Diatrizoate. Methods Patients with APSO were divided into A group(treated by oral Meglumine Diatizoate) and B group (treated by conventional methods).The effect was compared between the two groups .Results There was no death in A group. Mean defecation time, resident time and conservative treatmet time were apparently shorter than those in B group. There was no complication such as hypovolemia, abnormality of water and electrolyte, inhalation pneumonia, serious damage of the mucosa, aggravation of the obstrizoate and intestinal perforation in A group. Conclusion Oral Meglumine Diatrizoate is a simple,safe and effective method in the treatment of APSO.It has less complications,shortens resident time and has satisfactory clinical effect.